192 related articles for article (PubMed ID: 36581445)
1. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
[TBL] [Abstract][Full Text] [Related]
2. Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy.
Zhang Y; Zhu Y; Wang D; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
Heart Rhythm; 2023 Jul; 20(7):958-967. PubMed ID: 36870381
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction.
Choi YJ; Lee HJ; Park JS; Park CS; Rhee TM; Choi JY; Choi HM; Park JB; Yoon YE; Lee SP; Na JO; Cho GY; Kim YJ; Hwang IC; Kim HK
Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1374-1383. PubMed ID: 37467475
[TBL] [Abstract][Full Text] [Related]
4. Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.
Goldstein SA; Kennedy KF; Friedman DJ; Al-Khatib SM; Wang A
J Am Heart Assoc; 2023 Aug; 12(16):e029293. PubMed ID: 37586066
[TBL] [Abstract][Full Text] [Related]
5. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
[TBL] [Abstract][Full Text] [Related]
6. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
7. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
[TBL] [Abstract][Full Text] [Related]
9. Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy.
Lee HJ; Kim HK; Lee SC; Kim J; Park JB; Hwang IC; Choi YJ; Lee SP; Chang SA; Lee W; Park EA; Cho GY; Kim YJ
Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1108-1116. PubMed ID: 34542591
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
[TBL] [Abstract][Full Text] [Related]
11. Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.
Mahmod M; Raman B; Chan K; Sivalokanathan S; Smillie RW; Samat AHA; Ariga R; Dass S; Ormondroyd E; Watkins H; Neubauer S
J Cardiovasc Magn Reson; 2022 Jun; 24(1):36. PubMed ID: 35692049
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
13. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.
Chen QF; Hu J; Hu J; Nijjar PS; Xu J; Shi S; Liang D; Liao H; Gao J; Lin WH; You S; Zhou XD
Clin Res Cardiol; 2024 May; 113(5):761-769. PubMed ID: 38197895
[TBL] [Abstract][Full Text] [Related]
15. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians.
Choi YJ; Kim HK; Lee SC; Park JB; Moon I; Park J; Kim YJ; Sohn DW; Ommen S
Heart; 2019 Dec; 105(24):1892-1897. PubMed ID: 31383719
[TBL] [Abstract][Full Text] [Related]
16. Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy.
Klem I; Klein M; Khan M; Yang EY; Nabi F; Ivanov A; Bhatti L; Hayes B; Graviss EA; Nguyen DT; Judd RM; Kim RJ; Heitner JF; Shah DJ
Circulation; 2021 Apr; 143(14):1343-1358. PubMed ID: 33478245
[TBL] [Abstract][Full Text] [Related]
17. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
Norrish G; Ding T; Field E; Cervi E; Ziółkowska L; Olivotto I; Khraiche D; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Marrone C; Bökenkamp R; Baban A; Kubus P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Klaassen S; Ojala TH; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Sinagra G; Castro FJ; Stuart G; Vignati G; Yamazawa H; Barriales-Villa R; Garcia-Guereta L; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Siles A; Rasmussen TB; Calcagnino M; Jones CB; De Wilde H; Kubo T; Felice T; Popoiu A; Mogensen J; Mathur S; Centeno F; Reinhardt Z; Schouvey S; O'Mahony C; Omar RZ; Elliott PM; Kaski JP
Circ Arrhythm Electrophysiol; 2022 May; 15(5):e010075. PubMed ID: 35491873
[TBL] [Abstract][Full Text] [Related]
19. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
20. Evaluation of new predictive scores for sudden cardiac death in childhood hypertrophic cardiomyopathy in a French cohort.
Fontanges PA; Marquie C; Houeijeh A; Baudelet JB; Richard A; Amenyah C; Lucidarme S; Bonnet M; Delarue A; Bichali S; Assi NA; Marechaux S; Menet A; Vaksmann G; Godart F; Domanski O
Arch Cardiovasc Dis; 2024; 117(6-7):402-408. PubMed ID: 38821762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
